APLS
Apellis Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders +5.6% ·
aandelenstroom -1.9% ·
netto nieuwe posities 0.0%
— formule
Versnippering van eigendom — meer houders, kleinere totale positie
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q1 2026 | 99 | +3 | 79.10M | $3.12B | +14 | −12 |
| Q4 2025 | 97 | +1 | 73.39M | $1.84B | +2 | — |
| Q3 2025 | 19 | +1 | 50.24M | $1.14B | +1 | −1 |
| Q2 2025 | 16 | +2 | 43.69M | $756.24M | +2 | — |
| Q1 2025 | 11 | -2 | 24.93M | $545.30M | +1 | −3 |
| Q4 2024 | 13 | +2 | 23.82M | $760.24M | +3 | −1 |
| Q3 2024 | 10 | +2 | 20.37M | $587.46M | +2 | — |
| Q2 2024 | 8 | — | 21.17M | $811.69M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 9.99M | -1.6% | $226.01M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 2 | Morgan Stanley ✦ | 9.64M | — | $218.23M | 0.0% | n/c | 1 | SEC ↗ ×9 |
| 3 | Wellington Management ✦ | 9.29M | +3.5% | $210.25M | 0.0% | ▲ Add | 6 | SEC ↗ ×5 |
| 4 | BlackRock ✦ (passief) | 6.27M | -2.1% | $141.86M | 0.0% | ▼ Trim | 2 | SEC ↗ ×17 |
| 5 | AQR Capital Management ✦ | 4.49M | -24.9% | $101.55M | 0.1% | ▼ Trim | 6 | SEC ↗ ×5 |
| 6 | State Street Global Advisors ✦ (passief) | 4.04M | +13.3% | $91.37M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Geode Capital Management ✦ (passief) | 2.07M | +3.9% | $46.92M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 8 | Millennium Management ✦ | 1.34M | +563.7% | $30.41M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 9 | Renaissance Technologies ✦ | 722.89K | +6478.9% | $16.36M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 586.45K | +32.5% | $13.27M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 11 | D. E. Shaw & Co. ✦ | 456.79K | +81.9% | $10.34M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 12 | Marshall Wace ✦ | 396.74K | -85.3% | $8.98M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 13 | Two Sigma Investments ✦ | 252.07K | -38.0% | $5.70M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | Point72 Asset Management ✦ | 217.07K | Nieuw | $4.91M | 0.0% | New | 1 | SEC ↗ |
| 15 | Gotham Asset Management ✦ | 127.16K | +6.7% | $2.88M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 16 | Goldman Sachs Group ✦ | 124.37K | — | $2.81M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 17 | JPMorgan Chase ✦ | 107.03K | — | $2.42M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 18 | T. Rowe Price ✦ | 97.94K | +6.3% | $2.22M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 19 | Fidelity (FMR) ✦ | 18.50K | -4.1% | $418,717 | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Point72 Asset Management | $4.91M | 0.0% |
Verlaten
| Norges Bank | $40.98M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 320 houders, 137.95M aandelen, $5.43B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.